U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.
Source: WRAL News
Alzheimer's drug from Biogen, partner receives FDA approval
Published in Marshallberg
Be First to Comment